Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ETHK LabsHKSE:01931 -1.69%74 Days Payable is 87.12 as of Dec. 2025, which is 43% above its 10-year median of 60.85. GuruFocus rates HKSE:01931 with a GF Score™ of 74/100 and a GF Value™ of HK$1.38 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 116 Medical Distribution companies, ETHK Labs ranks better than 63.79% on this metric.
ETHK Labs's average Accounts Payable for the
six
months ended in Dec. 2025 was HK$667 Mil. ETHK Labs's Cost of Goods Sold for the
six
months ended in Dec. 2025 was HK$1,397 Mil.
Hence, ETHK Labs's Days Payable for the
six
months ended in Dec. 2025 was 87.12.
The historical rank and industry rank for ETHK Labs's Days Payable or its related term are showing as below:
HKSE:01931'
s Days Payable Range Over the Past 10 Years
Min: 36.35 Med: 60.85 Max: 99.69
Current: 96.64
During the past 10 years, ETHK Labs's highest Days Payable was 99.69. The lowest was 36.35. And the median was 60.85.
HKSE:01931's Days Payable is ranked better than 63.79% of 116
companies
in the Medical Distribution industry
Industry Median: 78.565
vs HKSE:01931: 96.64
ETHK Labs's Days Payable
increased
from Dec. 2024 (79.41) to Dec. 2025 (87.12).
It may suggest that ETHK Labsdelayed paying its suppliers.
The historical data trend for ETHK Labs's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, ETHK Labs's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's Days Payable distribution charts can be found below:
* The bar in red indicates where ETHK Labs's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
ETHK Labs's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a Days Payable of 87.12 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ETHK Labs and its competitors. This is 43% above median its historical median of 60.85. Over the past decade, ETHK Labs' Days Payable has ranged from 36.35 to 99.69. According to the industry distribution chart, ETHK Labs ranks #42 out of 116 companies in the Medical Distribution industry, placing it in the top 36.2%.
Is ETHK Labs' Days Payable too high?
ETHK Labs' current Days Payable of 87.12 is 43% above median its 10-year median of 60.85. Over the past 10 years, this metric has ranged from a low of 36.35 to a high of 99.69. The Medical Distribution industry median Days Payable is 78.57. ETHK Labs' value of 87.12 is 10.9% above this industry median. Based on the distribution chart, ETHK Labs ranks #42 out of 116 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #42 out of 116 companies for Days Payable. This puts ETHK Labs in the upper half of its industry. The industry median Days Payable is 78.57. ETHK Labs' value of 87.12 is 10.9% above this benchmark. Historically, ETHK Labs' own Days Payable has ranged from 36.35 to 99.69 over the past decade. While the company's 10-year median is 60.85 vs. the industry median of 78.57, ETHK Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 78.57, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ETHK Labs's current Days Payable of 87.12 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median Days Payable is 78.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current Days Payable is 87.12, which is 43% above median its own 10-year median of 60.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.58 — trading 58% below its estimated fair value. The current Days Payable is 87.12, which is 43% above median its 10-year median of 60.85 and 10.9% above the Medical Distribution industry median of 78.57. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current Days Payable is 87.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
Days Payable: 87.12 (43% above median its 10-year median of 60.85)
GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
Industry Position: 10.9% above the Medical Distribution median (#42 of 116)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
